A clinical trial to compare two different drug schedules used for prevention of post-operative nausea and vomiting in patients undergoing total abdominal hysterectomy
Phase 2
- Conditions
- Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary systemHealth Condition 2: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
- Registration Number
- CTRI/2023/08/056041
- Lead Sponsor
- Prashant Dhatwalia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Duration of surgery exceeding 1 hour
2. BMI <30 kg/m2
3. ASA physical status grade I and II.
4. Nonsmoker.
Exclusion Criteria
1. Patients with gastrointestinal disease.
2. History of motion sickness.
3. Previous history of PONV.
4. Pregnancy or menstruation.
5. Those who had taken anti-emetics within 24 hours before operation.
6. Diabetics.
7. Patients with full stomach.
8. Smokers.
9. History of opioids use.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PONV incidence in both the groups.Timepoint: 48 hours
- Secondary Outcome Measures
Name Time Method 1. Serial blood sugar levels <br/ ><br>2. Total analgesic requirement in 24 hrs <br/ ><br>3. Side effects like headache, dizziness, diarrhea, hypotension, bradycardia if any.Timepoint: 48 hours